Koch Institute Hosts 12th Annual "Cancer Immunology and Immunotherapy"...
One-day event will examine the latest breakthroughs in cancer immunotherapies.
View ArticleCancer Immunotherapy Breakthroughs Focus of KI Symposium
The recent release of promising clinical data from cancer immunotherapies in development has generated considerable optimism in the cancer research community. Following this excitement, on June 14,...
View ArticleWhy Tumors Become Drug-Resistant
A collaborative study at the Koch Institute for Integrative Cancer Research at MIT initially funded by a Koch Institute Frontier Research Program Award and led by faculty member Doug Lauffenburger...
View ArticleMIT Team Receives $10.4 Million Biomanufacturing Grant from DARPA
KI professor J. Christopher Love received a two-year award from the Defense Advanced Research Projects Agency (DARPA) to lead a new program to develop novel technologies for its Biologically-derived...
View ArticleNanoparticle Vaccine Offers Better Protection
In a recent study published in Science Translational Medicine, the Irvine lab showed how formulation of protein or peptide vaccines in lipid nanocapsules makes them much more durable inside the body...
View ArticleOne-two Punch Knocks Out Aggressive Tumors
The David H. Koch Professor in Engineering Paula Hammond and her team have designed layer-by-layer nanoparticles that disable tumors' defenses and make them much more vulnerable to chemotherapy.
View ArticleResistance Is Futile: Chemists Develop New Way to Kill Cancer Cells Resistant...
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.
View ArticleBiologists ID New Cancer Weakness
Biologists from the Koch Institute for Integrative Cancer Research at MIT have found that tumor cells with mutated p53 can be made much more vulnerable to chemotherapy by blocking another gene called MK2.
View ArticlePills of the Future: Nanoparticles
Researchers from the Koch Institute for Integrative Cancer Research at MIT, Brigham and Women's Hospital, and MIT's Department of Mechanical Engineering design drug-carrying nanoparticles that can be...
View ArticleNew Sensor Tracks Zinc in Cells
Scientists at the Koch Institute for Integrated Cancer Research at MIT are researching how shifts in zinc's location could be exploited for early diagnosis of prostate cancer.
View ArticleLudwig Cancer Research Gives $90 Million to MIT
The Ludwig Center at MIT is one of six centers to receive new financial support from Ludwig Cancer Research. Housed within the Koch Institute, MIT's Ludwig Center is focused on understanding metastasis.
View ArticleWeighing Particles at the Attogram Scale
New device from MIT can measure masses as small as one millionth of a trillionth of a gram, in solution.
View ArticleNew Weapon Fights Drug-Resistant Tumors
Biologists from MIT's Koch Institute identify a drug that can help wipe out reservoirs of cancer cells in bone marrow.
View ArticleBetter RNA Interference, Inspired by Nature
New MIT nanoparticles offer best-ever gene silencing, could help treat liver diseases
View ArticleHitchhiking Vaccines Boost Immunity
New MIT vaccines that catch a ride to immune cell depots could help fight cancer and HIV
View ArticleA Paper Diagnostic for Cancer
Low-cost urine test developed by MIT engineers amplifies signals from growing tumors to detect disease.
View ArticleHow Tumors Escape
Koch Institute biologists identify extracellular proteins that help aggressive tumors spread through the body.
View ArticleNew View of Tumors' Evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
View ArticleErasing a Genetic Mutation
MIT team reverses a liver disorder in mice by correcting a mutated gene
View ArticleHow to Build a Biotech Renaissance: MIT in Kendall Square
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT's biotech community helped revive Kendall Square
View Article
